Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU) - moderated -- Ignore unavailable to you. Want to Upgrade?

To: Karuna1 who wrote (46167)	5/19/2018 1:34:08 PM
From: erickerickson	3 Recommendations Recommended By EMU2 erippetoe idahoranch1 Read Replies (1) \| Respond to of 63276

"Isn't it still related to buy out" Only marginally. Think of it as a clause in a pre-nuptial agreement. I read it as "If, somewhere in the future, a buyout occurs, then Royalty's interests are protected in this area by this clause.....". There's nothing in there about when, just if. Nothing about any expectation that it'll occur at all. Nothing about any target price (note they are percentages of some unspecified Buyer and Seller Price). The contract (they ponied up $250M after all) has to take into account the possibility, however faint or far away, that a buyout happens. Or the lawyers who drew it up are incompetent. I suspect Royalty hopes it never occurs and IMMU grows sales to a gazillion dollars every year. This is just boilerplate, totally irrelevant to any speculation swirling around now. And the current speculation about a buy-out occurs pretty regularly whenever significant events happen. I've learned to not get excited by it, especially because there's nothing actionable here. Ask yourself the question "Would I buy more shares right now based on the possibility of a buy out?" 99.5% of the time the answer is "no", so why waste electrons discussing it? These are my last exercise of those poor tired electrons on this topic....